Home/CicloMed/Scott J. Weir, Pharm.D., Ph.D.
SJ

Scott J. Weir, Pharm.D., Ph.D.

Acting Chief Scientific Officer

CicloMed

Therapeutic Areas

CicloMed Pipeline

DrugIndicationPhase
Fosciclopirox (Ciclopirox Prodrug)Cisplatin-ineligible Muscle-Invasive Bladder Cancer (MIBC)Phase 1